Keyword Analysis & Research: emcure hiv

emcureshivupdates.com:443

https://www.emcureshivupdates.com:443/

WEBAt this Site, we are dedicated to providing the most up-to-date information on HIV treatment and management through our webinars, updated HIV guidelines and drug interaction checker.

DA: 95 PA: 84 MOZ Rank: 56

wikipedia.org:443

https://en.wikipedia.org:443/wiki/Emcure_Pharmaceuticals

OverviewAIDS initiativeOperationsInvestorsAnticancer portfolioPrice fixingControversies and recallsExternal linksEmcure voices its concerns on HIV/AIDS through its "Let's fight AIDS together" initiative and supplies Antiretroviral drugs to Africa, Asia Pacific and CIS. As a part of its corporate social responsibility it supports 'Taal', a pharmacy for HIV/AIDS patients run by HIV/AIDS patients. Emcure has license agreements with Bristol-Myers Squibb for Atazanavir and Gilead Sciences for Tenofovir as part of their Global Access Programs. Founder: Satish Mehta Founded: 1981; 42 years ago Number of employees: 11,000 (January 2022)

Founder: Satish Mehta

Founded: 1981; 42 years ago

Number of employees: 11,000 (January 2022)

DA: 21 PA: 4 MOZ Rank: 17

nejm.org:443

https://www.nejm.org:443/doi/full/10.1056/NEJMoa1902824

WEBJul 24, 2019 · A first-line regimen of tenofovir disoproxil fumarate (TDF) with either lamivudine (3TC) or emtricitabine (FTC) plus efavirenz … Author: Willem D F Venter, Michelle Moorhouse, Simiso Sokhela, Lee Fairlie, Nkuli Mashabane, Masebole Maseny... Publish Year: 2019

Author: Willem D F Venter, Michelle Moorhouse, Simiso Sokhela, Lee Fairlie, Nkuli Mashabane, Masebole Maseny...

Publish Year: 2019

DA: 93 PA: 77 MOZ Rank: 55

emcure.com:443

https://www.emcure.com:443/about-us-overview/

WEBSep 30, 2023 · Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others.

DA: 96 PA: 80 MOZ Rank: 94

emcureshivupdates.com:443

https://www.emcureshivupdates.com:443/blank

WEBEMCURES HIV UPDATES. THIS WEBSITE IS FOR WEBINAR RECORDINGS AND ALSO UPDATED HIV GUIDELINES SHARING WITH HEALTHCARE PROFESSIONALS.

DA: 7 PA: 88 MOZ Rank: 19

emcure.com:443

https://www.emcure.com:443/

WEBEmcure Pharmaceuticals Limited was built with the purpose and core belief of making E ffective M edicines to Cure patients enabling them to lead healthier lives. We are one of …

DA: 95 PA: 60 MOZ Rank: 14

nejm.org:443

https://www.nejm.org:443/doi/full/10.1056/NEJMoa1215541

WEBDolutegravir (S/GSK1349572), a once-daily, unboosted integrase inhibitor, was recently approved in the United States for the treatment of human immunodeficiency virus type 1 (HIV-1) infection...

DA: 73 PA: 44 MOZ Rank: 57

youtube.com:443

https://www.youtube.com:443/@hivupdates

WEBEmcure's HIV Updates is channel for scientific webinars with a purpose to share scientific updates in the field of HIV/AIDS happening all across world to all HIV …

DA: 7 PA: 58 MOZ Rank: 2

biovoicenews.com:443

https://biovoicenews.com:443/emcure-pharmaceuticals-conferred-with-merit-award-at-hiv-congress-2023/

WEBApr 8, 2023 · New Delhi: Emcure Pharmaceuticals, a leading Indian pharmaceutical company, has been felicitated for its contributions to HIV/AIDS research and development at the HIV Congress 2023, …

DA: 1 PA: 99 MOZ Rank: 57

nih.gov:443

https://www.ncbi.nlm.nih.gov:443/pmc/articles/PMC9375976/

WEBAug 10, 2022 · Conclusion. This study demonstrated the safety and efficacy of DTG based regimen in treatment naïve HIV-1 patients in Indian population and support use of DTG …

DA: 27 PA: 72 MOZ Rank: 71